Marin-Muller, C.; Li, D.; Lü, J.-M.; Liang, Z.; Vega-MartÃnez, O.; Crawford, S.E.; Estes, M.K.; Fisher, W.E.; Chen, C.; Yao, Q.
Nanoparticle-Mediated Therapy with miR-198 Sensitizes Pancreatic Cancer to Gemcitabine Treatment through Downregulation of VCP-Mediated Autophagy. Pharmaceutics 2023, 15, 2038.
https://doi.org/10.3390/pharmaceutics15082038
AMA Style
Marin-Muller C, Li D, Lü J-M, Liang Z, Vega-MartÃnez O, Crawford SE, Estes MK, Fisher WE, Chen C, Yao Q.
Nanoparticle-Mediated Therapy with miR-198 Sensitizes Pancreatic Cancer to Gemcitabine Treatment through Downregulation of VCP-Mediated Autophagy. Pharmaceutics. 2023; 15(8):2038.
https://doi.org/10.3390/pharmaceutics15082038
Chicago/Turabian Style
Marin-Muller, Christian, Dali Li, Jian-Ming Lü, Zhengdong Liang, Osvaldo Vega-MartÃnez, Sue E. Crawford, Mary K. Estes, William E. Fisher, Changyi Chen, and Qizhi Yao.
2023. "Nanoparticle-Mediated Therapy with miR-198 Sensitizes Pancreatic Cancer to Gemcitabine Treatment through Downregulation of VCP-Mediated Autophagy" Pharmaceutics 15, no. 8: 2038.
https://doi.org/10.3390/pharmaceutics15082038
APA Style
Marin-Muller, C., Li, D., Lü, J. -M., Liang, Z., Vega-MartÃnez, O., Crawford, S. E., Estes, M. K., Fisher, W. E., Chen, C., & Yao, Q.
(2023). Nanoparticle-Mediated Therapy with miR-198 Sensitizes Pancreatic Cancer to Gemcitabine Treatment through Downregulation of VCP-Mediated Autophagy. Pharmaceutics, 15(8), 2038.
https://doi.org/10.3390/pharmaceutics15082038